Loading...

SOHO 2026 Annual Meeting

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.

1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

ePostersLive by SciGen Technologies S.A. All rights reserved.

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Home Posters by Code Posters by Title Authors Affiliations Topics Sessions Videos Audios Previous meetings

Topics

Select Topic

Showing 54 results for "Hodgkin Lymphoma (HL)".

Thumbnail for The Hidden Burden After Lymphoma: Secondary Solid Malignancy Mortality Across the United States

HL - 505

The Hidden Burden After Lymphoma: Secondary Solid Malignancy Mortality Across the United States

Eric Wah Sanji

Poster Presenter: Eric Wah Sanji

Thumbnail for Frontline ABVD Chemotherapy Outcomes in Hodgkin Lymphoma in a Resource-Limited Setting: Real-World Survival and Prognostic Factors

HL - 582

Frontline ABVD Chemotherapy Outcomes in Hodgkin Lymphoma in a Resource-Limited Setting: Real-World Survival and Prognostic Factors

Hammad Javed

Poster Presenter: Hammad Javed

Thumbnail for Stepwise Increase in Mortality With Acute Organ Dysfunction Burden in Lymphoma Hospitalizations: A National Inpatient Sample Analysis (2018-2023)

Previous 1 2 3 4 5 6 Next

Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

HL - 607

Stepwise Increase in Mortality With Acute Organ Dysfunction Burden in Lymphoma Hospitalizations: A National Inpatient Sample Analysis (2018-2023)

Ramsha Khan

Poster Presenter: Ramsha Khan

Thumbnail for Tumor Lysis Syndrome as a Major Driver of Mortality and Renal Failure in Hospitalized Lymphoma Patients: A National Inpatient Sample Analysis (2018-2023)

HL - 618

Tumor Lysis Syndrome as a Major Driver of Mortality and Renal Failure in Hospitalized Lymphoma Patients: A National Inpatient Sample Analysis (2018-2023)

Ramsha Khan

Poster Presenter: Ramsha Khan

Thumbnail for Overall Survival and Prognostic Factors in Lymph Node Accessory Cell Tumors: APopulation-Based Analysis of the SEER Database (2000-2022)

HL - 650

Overall Survival and Prognostic Factors in Lymph Node Accessory Cell Tumors: APopulation-Based Analysis of the SEER Database (2000-2022)

Madho Mal

Poster Presenter: Madho Mal

Thumbnail for Safety and Efficacy of Brentuximab Vedotin With Adriamycin, Vinblastine, and Dacarbazine in Untreated Advanced-Stage Classical Hodgkin Lymphoma: A Preliminary Real-World Indian Experience

HL - 659

Safety and Efficacy of Brentuximab Vedotin With Adriamycin, Vinblastine, and Dacarbazine in Untreated Advanced-Stage Classical Hodgkin Lymphoma: A Preliminary Real-World Indian Experience

Ajay Gogia

Poster Presenter: Ajay Gogia

Thumbnail for Real-World Safety and Efficacy of Frontline Nivolumab Combined with Doxorubicin, Vinblastine, and Dacarbazine in Adult Classical Hodgkin Lymphoma

HL - 663

Real-World Safety and Efficacy of Frontline Nivolumab Combined with Doxorubicin, Vinblastine, and Dacarbazine in Adult Classical Hodgkin Lymphoma

Ajay Gogia

Poster Presenter: Ajay Gogia

Thumbnail for Primary Bone Marrow Hodgkin Lymphoma in Adults: A Systematic Review of Clinical Features, HIV/EBV Associations, and HLH Overlap

HL - 671

Primary Bone Marrow Hodgkin Lymphoma in Adults: A Systematic Review of Clinical Features, HIV/EBV Associations, and HLH Overlap

Anthony Navarrete Rios

Poster Presenter: Anthony Navarrete Rios

$Thumbnail for Role of targeted Immune therapies in relapsed refractory hodgkins lymphoma -A Multicentre experience from various transplant centres in Pakistan . A Lower middle income country perspective$

HL - 686

Role of targeted Immune therapies in relapsed refractory hodgkins lymphoma -A Multicentre experience from various transplant centres in Pakistan . A Lower middle income country perspective

Muhammad Sher Ali

Poster Presenter: Muhammad Sher Ali

ePosters in

Topics Sessions

Acute Lymphoblastic Leukemia (ALL)(71)Acute Myeloid Leukemia (AML)(230)Aggressive B-Cell Lymphoma (ABCL)(114)Cellular Therapy (CT)(128)Chronic Lymphocytic Leukemia (CLL)(110)Chronic Myeloid Leukemia (CML)(55)Hodgkin Lymphoma (HL)(54)Indolent B-Cell Lymphoma (IBCL)(47)Mantle Cell Lymphoma (MCL)(23)Multiple Myeloma (MM)(234)

Previous 1 2 Next

Sponsors